Goldman Sachs Group Inc

Filing Details

13F-HR/A2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-16
Total Holdings
11,314
Total Value
470725650026
Accession Number
0000769993-25-000301
Form Type
13F-HR/A
Manager Name
Goldman Sachs Group Inc
Data Enrichment
86% identified
9,763 identified1,551 unidentified

Holdings

11,314 positions
Manager:
Search and click to pin securities to the top
Page 224 of 253
908 Devices Inc.
Shares:
74656(-71.7%)
Value:
$334.5M(-42.5%)
TELOS CORP
Shares:
140413(-44.1%)
Value:
$334.2M(-61.1%)
Guardian Pharmacy Services, Inc.
Shares:
15515(-90.9%)
Value:
$329.8M(-90.5%)
Zevia PBC
Shares:
152056(-44.8%)
Value:
$328.4M(-71.5%)
TPI COMPOSITES, INC
Shares:
406512(-19.4%)
Value:
$327.6M(-65.6%)
Contango ORE, Inc.
Shares:
31868(-18.1%)
Value:
$325.4M(-16.5%)
46654Q781
Shares:
5108
Value:
$325.2M
46435G219
Shares:
7189(-5.1%)
Value:
$323.6M(-3.7%)
33833Q106
Shares:
60523(+14.2%)
Value:
$323.2M(+61.4%)
81141RAF7
Shares:
0
Value:
$322.4M(-87.5%)
46436E858
Shares:
14034(-78.9%)
Value:
$321.9M(-78.8%)
Karyopharm Therapeutics Inc.
Shares:
85410
Value:
$319.4M
45782C664
Shares:
7640
Value:
$319.2M
Nuveen AMT-Free Quality Municipal Income Fund
Shares:
28492
Value:
$319.1M
Navios Maritime Partners L.P.
Shares:
8121(-39.0%)
Value:
$318.5M(-44.7%)
Inmune Bio, Inc.
Shares:
40716(-36.0%)
Value:
$318.0M(+7.0%)
scPharmaceuticals Inc.
Shares:
120897(-70.5%)
Value:
$318.0M(-78.1%)
bluebird bio, Inc.
Shares:
64950(+4.7%)
Value:
$317.0M(-38.7%)
Endava plc
Shares:
16244(-53.0%)
Value:
$316.9M(-70.3%)
682189AS4
Shares:
0
Value:
$316.9M(-19.3%)